Racial/ethnic disparities in initiation and persistent use of anti-dementia medications.

ABSTRACT:

Background

Racial/ethnic disparities in anti-dementia medications use in longitudinally followed research participants are unclear.

Methods

The study included initially untreated participants followed in National Alzheimer's Coordinating Center Uniform Data Set who were ≥65 at baseline with Alzheimer's disease dementia.

Outcomes

Outcomes for acetylcholinesterase inhibitor (AChEI) treatment included (1) any new AChEI treatment during follow-up, and (2) persistence of treatment during follow-up categorized into: intermittent treatment (< 50% follow-ups reporting treatment), persistent (≥50% follow-ups), and always treated. Outcomes for memantine treatment were similarly constructed.

Results

Controlling for participant characteristics, Black and Hispanic participa

SUBMITTER: Zhu CW 

PROVIDER: S-EPMC9402814 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature